Short-Acting β₂-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6

Authors: Luis J. Nannini

Published: 2020-07-20

DOI: 10.1164/rccm.202006-2297le

Source: Full article

---

Abstract

No abstract found.